NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022… | New

MOUNTAIN VIEW, Calif., July 21. 10, 2022 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that it will release a financial report second quarter 2022 results after market close on Thursday, August 11, 2022. Company management will webcast a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. EST.

Investors interested in listening to the conference call can do so by following one of the links below:

  • Webcast link for interested listeners:
  • Dial-in listing for sell-side research analysts:

Live audio of the webcast will be available in the “Investors” section of the Company’s website at: https://investors.neuropace.com.

An archived recording will be available in the “Investors” section of the Company’s website at: https://investors.neuropace.com. Webcasts may be rebroadcast for at least 90 days after the event.

About NeuroPace, Inc.

Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel differentiated RNS system is the first and only commercially available brain-aware platform that delivers real-time, personalized treatment at the source of the seizure. This platform can lead to better quality of care for patients with drug-resistant epilepsy and has the potential to offer a more personalized solution and better outcomes for the large population of patients with other brain disorders.

Investor contacts:

Gilmartin Group

Matt Basso, CFA

[email protected]

Copyright 2022 GlobeNewswire, Inc.

About Michael Bill

Check Also

Edinburgh mum urges UK government to help fund high costs of medicinal cannabis for children with epilepsy

An Edinburgh mum, who has campaigned for years for cannabis oils to be prescribed by …